Why Now

Why Now

  • Polish healthcare expenditures amount to approx. 24 billion EUR
  • In the new financial plan for 2016 to 2020, approximately 2.4 billion EUR will be allocated for
    financing the healthcare sector.
  • The country’s Ministry of Science and Higher Education also budgeted 302 million EUR for
    biotechnology development.
  • Clinical trials have experienced an increase in the last years, due to innovation-friendly policies
    and incentives.
  • Poland is becoming an emerging hotspot for pharmaceutical companies and biotech startups.
  • Poland’s pharmaceutical sector worth approximately 8 billion EUR.
  • Polish pharmaceutical companies are continuously growing their product & service sales globally.
  • Poland’s medical technology sector is valued at approx. 1.6 billion EUR and is expected to grow 10% annually in the coming three years.